Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Dibyendu Paik"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 111, Iss, Pp 224-235 (2019)
Leishmaniasis is a parasite-mediated tropical disease affecting millions of individuals worldwide. The available antileishmanial chemotherapeutic modalities exhibit adverse toxicity, exorbitant price and advent of drug-resistant parasites. Hence, pla
Publikováno v:
Microbes and Infection. 20:37-47
This study is aimed to evaluate the protective effect of L. donovani intracellular serine protease (SP-Ld) in combination with Freund's adjuvant and liposomal formulations against experimental visceral leishmaniasis (VL). The animals were immunized w
Publikováno v:
International Immunopharmacology. 85:106623
To overcome the drug toxicity and frequent resistance of parasites against the conventional drugs for the healing of human visceral leishmaniasis, innovative plant derived antileishmanial components are very imperative. Fuelled by the complications o
Publikováno v:
Parasitology international. 71
In pursuit of effective, safe and affordable antileishmanial drugs, the current study was designed to explore Corchorus capsularis L. leaf extract (CCEx) as an effective leishmanicidal substitute against Leishmania donovani. The leaf extract displays
Autor:
Tapati Chakraborti, Asmita Pramanik, Pijush Kanti Pramanik, Partha Das, Dibyendu Paik, Nur Alam
Publikováno v:
Proteases in Human Diseases ISBN: 9789811031618
Autophagy is a ubiquitous eukaryotic cellular process, in which cells degrade their own cytoplasmic components by hydrolases within the lysosome. Among many processes, the proteolytic processing of autophagy mediator protein Atg8 is catalyzed by a cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ceb8508f7d79a4e500ce1ed4874c763
https://doi.org/10.1007/978-981-10-3162-5_14
https://doi.org/10.1007/978-981-10-3162-5_14
Publikováno v:
Experimental Parasitology. 146:11-19
Leishmaniasis, a neglected tropical disease (NTD) causes major health problems in the tropical and subtropical world. Most of the antileishmanial modern therapies with different formulations of pentavalent antimonials, Miltefosine, Amphotericin B etc
Publikováno v:
Current microbiology. 74(1)
The conventional drugs used for the treatment of human visceral leishmaniasis have concerns about the toxicity and most importantly parasite resistance. To overcome these troubles, more efforts are made for the development of innovative therapeutic a
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 83
The increasing number of drug resistance issue of Leishmania donovani strain to common drugs compels to develop new therapeutics against leishmaniasis with minimal toxicity. In this regard, bioactive phytocomponents may lead to the discovery of new m
Publikováno v:
Indian journal of experimental biology. 53(11)
In visceral leishmaniasis (VL), development of alternative safe therapeutic strategy is gaining paramount wherein natural components of plant origin have prominence. We explored Coccinia grandis (L.) Voigt, a medicinal plant known in traditional folk
Autor:
Partha, Das, Md Nur, Alam, Dibyendu, Paik, Kanchan, Karmakar, Tripti, De, Tapati, Chakraborti
Publikováno v:
Indian journal of biochemistrybiophysics. 50(5)
Leishmaniasis is a deadly protozoan parasitic disease affecting millions of people worldwide. The treatment strategy of Leishmania infection depends exclusively on chemotherapy till date. But the treatment of the disease is greatly hampered due to hi